ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.154,79
0,44%
S&P 500
5.221,42
-0,02%
US Dollar vs BRL
5,1572
0,03%
Bitcoin
61.702,41
-1,91%
Brent Oil
83,045
-0,20%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Iovance Biotherapeutics Inc (IOVA)

  7. Iovance Biotherapeutics Inc (IOVA) Notícias

IOVA Iovance Biotherapeutics Inc

10,70
-0,18 (-1,65%)
Pré-mercado
Última atualização: 07:44:06
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Iovance Biotherapeutics Inc IOVA NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
-0,18 -1,65% 10,70 07:44:06
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
10,88
mais cotações »

Notícias Recentes

Data Hora Fonte Título
09/05/202417:01GLOBEIovance Biotherapeutics Reports First Quarter 2024 Financial..
01/05/202407:01GLOBEIovance Biotherapeutics to Host First Quarter 2024 Financial..
30/04/202407:01GLOBEIovance Biotherapeutics to Present at Upcoming Conferences
24/04/202417:01GLOBEIovance Biotherapeutics to Present Clinical and..
19/04/202418:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
22/03/202418:30GLOBEIovance Biotherapeutics Reports Inducement Grants under..
04/03/202408:30GLOBEIovance Biotherapeutics Announces FDA has Lifted Clinical..
01/03/202419:00GLOBEIovance Biotherapeutics to Present at Upcoming Conferences
28/02/202418:01GLOBEIovance Biotherapeutics Reports Fourth Quarter and Full Year..
22/02/202410:45GLOBEIovance Biotherapeutics to Host Fourth Quarter and Full-Year..
20/02/202408:30GLOBEIovance Biotherapeutics, Inc. Announces Pricing of $211..
16/02/202419:30GLOBEIovance Biotherapeutics Reports Inducement Grants under..
16/02/202417:38GLOBEIovance Biotherapeutics to Host Conference Call and Webcast..
16/02/202417:19GLOBEIovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA..
19/01/202419:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
28/12/202309:27IHMARKETNEWSWall Street Highlights: Amazon to Introduce Ads on Prime..
27/12/202309:54DJNIovance Shares Fall Premarket As FDA Places Study On Hold..
27/12/202309:00GLOBEIovance Biotherapeutics Announces Clinical Program Update..
22/12/202319:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
17/11/202319:00GLOBEIovance Biotherapeutics Reports Inducement Grants under..
07/11/202318:01GLOBEIovance Biotherapeutics Reports Third Quarter and..
31/10/202317:01GLOBEIovance Biotherapeutics to Host Third Quarter and..
31/10/202310:05GLOBEIovance Biotherapeutics to Present Clinical and Pre-Clinical..
20/10/202318:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
16/10/202309:15GLOBEIovance Biotherapeutics Announces Clinical Data for..
27/09/202317:01GLOBEIovance Biotherapeutics to Present Clinical and Pre-Clinical..
22/09/202319:25GLOBEIovance Biotherapeutics Reports Inducement Grants under..
14/09/202319:10GLOBEU.S. Food and Drug Administration Updates Prescription Drug..
07/09/202308:31GLOBEIovance Biotherapeutics to Present at 2023 Wells Fargo..
18/08/202318:00GLOBEIovance Biotherapeutics Reports Inducement Grants under..
08/08/202317:01GLOBEIovance Biotherapeutics Reports Second Quarter and First..
25/07/202317:01GLOBEIovance Biotherapeutics to Present Clinical Data for Tumor..
24/07/202317:01GLOBEIovance Biotherapeutics to Host Second Quarter 2023..
21/07/202318:34GLOBEIovance Biotherapeutics Reports Inducement Grants under..
13/07/202317:01GLOBEIovance Biotherapeutics Announces Closing of $172.5 Million..
10/07/202322:46GLOBEIovance Biotherapeutics, Inc. Announces Pricing of Its..
10/07/202317:34GLOBEIovance Biotherapeutics, Inc. Announces Proposed Public..
10/07/202311:56DJNIovance Biotherapeutics Shares Rise 12% After Positive Lung..
10/07/202308:00GLOBEIovance Biotherapeutics Announces Regulatory and Clinical..
20/06/202308:01GLOBEIovance Biotherapeutics to Host Virtual Roundtable with Key..
15/06/202308:01GLOBEIovance Biotherapeutics Announces First Patient Randomized..
09/06/202308:01GLOBEIovance Biotherapeutics to Present at Jefferies Global..
26/05/202320:05DJNIovance Shares Shares Get After-Hours Boost From FDA..
26/05/202318:30GLOBEIovance Biotherapeutics Announces U.S. Food and Drug..

Seu Histórico Recente

NASDAQ
IOVA
Iovance Biotherapeutics
ASX
DYE
Dyesol
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados